Cập nhật nghiên cứu về chẩn đoán-điều trị sốt rét đăng tải trên tạp chí quốc tế nổi tiếng năm 2016-2017

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas

Differences in parasite transmission intensity influence the process of acquisition of host immunity to Plasmodium falciparum malaria and ultimately, the rate of malaria related morbidity and mortality. Potentia...

Bright Adu, Mariama K. Cherif, Samuel Bosomprah, Amidou Diarra, Fareed K. N. Arthur, Emmanuel K. Dickson, Giampietro Corradin, David R. Cavanagh, Michael Theisen, Sodiomon B. Sirima, Issa Nebie and Daniel Dodoo

Malaria Journal 2016 15:123

Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana

The use of artemisinin-based combination therapy (ACT) as first-line treatment for uncomplicated malaria was a policy recommended by World Health Organization. In 2004, Ghana changed her first-line anti-malari...

Samuel Chatio, Raymond Aborigo, Philip Baba Adongo, Thomas Anyorigiya, Philip Ayizem Dalinjong, Patricia Akweongo and Abraham Oduro

Malaria Journal 2016 15:125

Anopheles subpictus carry human malaria parasites in an urban area of Western India and may facilitate perennial malaria transmission

India contributes 1.5–2 million annual confirmed cases of malaria. Since both parasites and vectors are evolving rapidly, updated information on parasite prevalence in mosquitoes is important for vector manage...

Ashwani Kumar, Rajeshwari Hosmani, Shivaji Jadhav, Trelita de Sousa, Ajeet Mohanty, Milind Naik, Adarsh Shettigar, Satyajit Kale, Neena Valecha, Laura Chery and Pradipsinh K. Rathod

Malaria Journal 2016 15:124

Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014–2017: an analysis of national allocations and regional grants

The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) has been the largest financial supporter of malaria since 2002. In 2011, the GFATM transitioned to a new funding model (NFM), which prioritizes ...

Brittany Zelman, Melissa Melgar, Erika Larson, Allison Phillips and Rima Shretta

Malaria Journal 2016 15:118

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach

Countries of the greater Mekong subregion have made a transition from malaria control to an aim for falciparum and vivax malaria elimination. The elimination of falciparum malaria will have to be achieved agai...

Sara E. Canavati, Harriet L. S. Lawford, Bayo S. Fatunmbi, Dysoley Lek, Narann Top-Samphor, Rithea Leang, Arjen M. Dondorp, Rekol Huy and Walter M. Kazadi

Malaria Journal 2016 15:120

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction

Combination therapy with artesunate plus sulfadoxine-pyrimethamine (SP) was adopted as recommended treatment for Plasmodium falciparum infection in Afghanistan in 2003.

Ghulam Rahim Awab, Mallika Imwong, Sasithon Pukrittayakamee, Fazel Alim, Warunee Hanpithakpong, Joel Tarning, Arjen M. Dondorp, Nicholas P. J. Day, Nicholas J. White and Charles J. Woodrow

Malaria Journal 2016 15:121

Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials

The US FDA recently developed CD3+, a counterfeit detection tool that is based on sample illumination at specific wavelengths of light and visual comparison of suspect sample and packaging materials to an auth...

JaCinta S. Batson, Daniel K. Bempong, Patrick H. Lukulay, Nicola Ranieri, R. Duane Satzger and Leigh Verbois

Malaria Journal 2016 15:119

Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection

Plasmodium vivax malaria is a major public health problem in India. Control of vivax malaria is challenging due to various factors including relapse which increase the burden significa...

Ram Das, Ramesh C. Dhiman, Deepali Savargaonkar, Anupkumar R. Anvikar and Neena Valecha

Malaria Journal 2016 15:115

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of ...

Aye A. Win, Mallika Imwong, Myat P. Kyaw, Charles J. Woodrow, Kesinee Chotivanich, Borimas Hanboonkunupakarn and Sasithon Pukrittayakamee

Malaria Journal 2016 15:110

Simultaneous quantification of artesunate and mefloquine in fixed-dose combination tablets by multivariate calibration with middle infrared spectroscopy and partial least squares regression

Malaria is one of the most lethal and life-threatening infectious diseases in the world, causing more than half a million deaths annually. Treatment with mefloquine and artesunate is currently recommended by t...

Breno Maurício Marson, Raquel de Oliveira Vilhena, Camilla Regina de Souza Madeira, Flávia Lada Degaut Pontes, Mário Sérgio Piantavini and Roberto Pontarolo

Malaria Journal 2016 15:109

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015)

The Malaria Policy Advisory Committee (MPAC) to the World Health Organization held its eighth meeting in Geneva, Switzerland from 16 to 18 September 2015. This article provides a summary of the discussions, co...

Malaria Journal 2016 15:117